Douglas G. Cole - Director at Denali Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
DNLI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Douglas G. Cole since 12 Feb 2025

Holdings reported by Douglas G. Cole for Denali Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 26,564 $489,309 $18.42 01 Jun 2023 Direct
Stock Option (right to buy) 12,649 01 Jun 2023 Direct Common Stock

Transactions reported by Douglas G. Cole for Denali Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.